Povej prijatelju o tem izdelku:
The Pharmagellan Guide to Biotech Forecasting and Valuation Frank S David
Naročeno iz oddaljenega skladišča
Božična darila lahko vrnete do 31. januarja
Kaj pravijo naše stranke:
The Pharmagellan Guide to Biotech Forecasting and Valuation
Frank S David
If you're a biotech executive, investor, deal maker, entrepreneur, or adviser--or aspire to be one--then you need to know how to build and analyze forecasts and valuation models of R& D-stage drugs.
THE PHARMAGELLAN GUIDE TO BIOTECH FORECASTING AND VALUATION is a comprehensive, thoroughly referenced handbook to creating and interpreting financial models for early-stage biopharma assets and companies.
- Vetted benchmarks for key drivers of income, expenses, and valuation.
- Proprietary analyses by Pharmagellan's experienced consulting team.
- More than 150 current references from peer-reviewed research, industry white papers, and SEC filings.
Whether you're making investment decisions, pitching to potential partners or funders, or assessing your own R& D program, this is the one-stop guide you need by your side.
| Medij | Knjige Paperback Book (Knjiga z mehkimi platnicami in lepljenim hrbtom) |
| Izdano | 6. januarja 2017 |
| ISBN13 | 9780998407500 |
| Založniki | Pharmagellan, LLC |
| Strani | 138 |
| Dimenzije | 152 × 229 × 8 mm · 213 g |
| Jezik | Angleščina |
